Skip to main content

Table 5 EORTC QLQ-C30 symptom scores by clinical characteristics of gynaecological cancer patients at TASH, Addis Ababa, Ethiopia, 2014(n = 140)

From: Health related quality of life of gynaecologic cancer patients attending at Tikur Anbesa Specialized Hospital (TASH), Addis Ababa, Ethiopia

Variables Fatigue Nausea &
vomiting
Pain Dyspnea Insomnia Diarrhea Financial difficulties constipation Appetite loss
Parity 0 25.92(±15.18) 5.56(±13.61) 33.33(±14.91) 16.67(±27.89) 16.67(27.89) 0.00(±0.00) 27.78(±32.78) 11.11(±27.22) 38.89(±38.97)
1-4 48.69(±29.36) 6.74(15.01) 47.87(±29.20) 5.67(±17.47) 31.91(36.08) 1.41(±6.80) 58.87(±33.48) 37.58(±39.69) 32.62(36.44)
5-9 59.68(±26.77) 10.71(±21.43) 61.43(28.31) 7.14(±18.73) 39.99(±31.90) 1.43(±8.86) 72.38(±28.36) 50.48(±36.66) 55.24(±34.46)
≥10 54.90(±30.30) 2.94(±6.55) 56.86(±33.88) 3.92(±11.07) 39.21(±33.82) 0.00(±0.00) 62.74(±35.12) 49.01(±44.28) 31.37(±34.33)
P value 0.015 0.35 0.024 0.49 0.28 0.87 0.003 0.05 0.003
Stage Stage 1 32.41(±26.58) 9.72 ± 28.83) 33.34(±22.47) 2.78(±9.62) 25.00 ± 28.87 0.00 ± 0.00 55.55 ± 38.49 22.22 ± 41.03 22.22 ± 38.48
Stage 2 49.43(±24.33) 3.40(±8.32) 50.68(±26.78) 4.08(±12.97) 27.89 ± 29.93 0.68 ± 4.76 67.35 ± 30.80 33.33 ± 34.70 36.06 ± 31.80
Stage 3 and 4 66.07 ± 28.70 8.93 ± 19.846 70.54 ± 27.34 7.14 ± 19.81 49.41 ± 35.39 1.78 ± 9.89 70.24 ± 28.20 63.69 ± 36.11 51.19 ± 37.05
P-value <0.001* 0.219 <0.001* 0.536 0.002* 0.649 0.320 <0.001* 0.013*
Cancer type Cervical, vaginal vulvar 55.95 ± 29.11 5.51 ± 14.91 58.78 ± 29.17 4.46 ± 15.17 37.80 ± 34.51 0.89 ± 7.02 67.56 ± 30.50 46.73 ± 39.13 41.96 ± 36.00
Ovarian 53.97 ± 20.87 24.60 ± 25.61 46.83 ± 26.15 20.64 ± 26.83 33.33 ± 27.89 3.17 ± 10.03 58.73 ± 36.37 39.68 ± 40.30 61.91 ± 33.81
Endometrial 22.22 ± 22.22 2.38 ± 6.30 21.43 ± 23.00 0.00 ± 0.00 19.05 ± 32.53 0.00 ± 00.00 38.10 ± 40.50 19.05 ± 26.23 23.81 ± 41.79
P value 0.009* 0.000* 0.002* 0.000* 0.330 0.394 0.042* 0.161 0.023*
  1. Independent t test (for two groups comparison) and one way ANOVA (for three and above group comparison) were employed,,* significant at p-value less than 0.05